TPMT/NUDT15 pharmacogenetic testing now commissioned

TPMT and NUDT15 pharmacogenetic testing is now commissioned on the NHS for both adult and paediatric patients with Acute Lymphoblastic Leukaemia only, the updated  national genomic test directory can be found here

These pharmacogenetic tests will identify if a patient is susceptible to an increased risk of myelosuppression when treated with thiopurines, such as 6-mercaptopurine (6MP).

For adult patients the dosing guidelines can be found here. It is important to note that these guidelines give dosing recommendations for 6MP for patients aged 25 years or older only and consider only the most common TPMT/NUDT15 variants. The recommendations in the guidelines are not intended to guide the treatment of patients under 25 years, or patients enrolled in a research study and in such circumstances, clinical staff should consult the research study treatment protocol or the locally agreed treatment protocol.

If you have any questions, please contact [email protected] and [email protected] OR please contact the authors of the guidelines.

Latest News

By BOPA Committee on 12th July 2024

TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients

BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients. It is estimated that one…

Read article
By BOPA Committee on 11th July 2024

Round Table Discussion at #BOPA2024

  As an exciting addition to the 2024 conference, we invite you all to participate in one of our interactive sessions on the Sunday morning. We have a lineup of…

Read article
By BOPA Committee on 10th July 2024

APTUK Position Statement for DHSC PGD Update

The Association of Pharmacy Technicians UK (APTUK), as the professional leadership body for pharmacy technicians, welcome the positive outcome of the DHSC consultation supporting the enabling of registered pharmacy technicians…

Read article
By BOPA Research on 9th July 2024

Last Chance to Submit Your Work to #BOPA2024

Last Chance to Submit: BOPA 2024 Abstract Submission DEADLINE is 14th July 2024. Delegates are invited to present results of their clinical and technical work as a poster with some…

Read article